Total meibomian gland loss in Parkinson’s disease
Orbit · 2025
DOI: 10.1080/01676830.2025.2475840 ↗Kurz gefasst
Fallbericht in der Zeitschrift Orbit, 2025. Verfasst von Prajakta Dandekar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cornea, Shantilal Shanghvi Eye Institute, Mumbai, India. Hauptthemen laut MEDLINE: Dry Eye Syndromes, Meibomian Gland Dysfunction, Parkinson Disease. Die Arbeit nennt 6 Literaturangaben. Gefördert von: Hyderabad Eye Research Foundation.
Abstract (Originalsprache)
Parkinson's disease is characterized by motor dysfunction, affecting blink frequency in the eyes. Reduced blinking and use of anticholinergic medications result in dry eye disease (DED) in these patients. This unique case had complete meibomian gland loss seen on meibography with reduced blinking and lacrimal gland function as well attributed to Parkinson's and its treatment. The autoimmune workup was negative, and the final diagnosis of drug-induced DED was made. The patient was managed with ocular lubricants and anti-inflammatory eye drops.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cornea, Shantilal Shanghvi Eye Institute, Mumbai, India.
- Brien Holden Eye Research Center (BHERC), LV Prasad Eye Institute, Hyderabad, India.
Förderung
- Hyderabad Eye Research Foundation
Zitieren
APA
Dandekar, P., & Singh, S. (2025). Total meibomian gland loss in Parkinson’s disease. Orbit. https://doi.org/10.1080/01676830.2025.2475840
Vancouver
Dandekar P, Singh S. Total meibomian gland loss in Parkinson’s disease. Orbit. 2025. doi:10.1080/01676830.2025.2475840
BibTeX
@article{Dandekar2025,
author = {Dandekar, Prajakta and Singh, Swati},
title = {Total meibomian gland loss in Parkinson’s disease},
journal = {Orbit},
year = {2025},
doi = {10.1080/01676830.2025.2475840}
}
EUVIMED